BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36968754)

  • 1. Improving adherence to immunosuppression after liver or kidney transplantation in individuals with impairments in personality functioning - A randomized controlled single center feasibility study.
    Wagner-Skacel J; Fink N; Kahn J; Dalkner N; Jauk E; Bengesser S; Mairinger M; Schüssler G; Pieh C; Stadlbauer V; Kirsch AH; Zitta S; Rosenkranz AR; Fickert P; Schemmer P
    Front Psychol; 2023; 14():1150548. PubMed ID: 36968754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to, and patient convenience of, prolonged-release tacrolimus in stable kidney and liver transplant recipients after conversion from immediate-release tacrolimus in routine clinical practice in Switzerland.
    Bonani M; Balaphas A; Bedino G; Bühler L; Dutkowski P; Fausch K; Gluderer S; Graf N; Hirt-Minkowski P; Müllhaupt B; Schönholzer C; Schulz MM; Venzin R; Wüthrich RP
    Swiss Med Wkly; 2021 Feb; 151():w20453. PubMed ID: 33638353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Randomized Trial Investigating the Influence of Pharmaceutical Care on the Intra-Individual Variability of Tacrolimus Concentrations Early After Kidney Transplant.
    Bessa AB; Felipe CR; Hannun P; Sayuri P; Felix MJ; Ruppel P; Ferreira AN; Cristelli MP; Viana L; Mansur JB; Basso G; Aguiar WF; Tedesco-Silva H; Medina-Pestana J
    Ther Drug Monit; 2016 Aug; 38(4):447-55. PubMed ID: 27414973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation.
    Doesch AO; Mueller S; Akyol C; Erbel C; Frankenstein L; Ruhparwar A; Ehlermann P; Dengler TJ; Katus HA
    Drug Des Devel Ther; 2013; 7():1253-8. PubMed ID: 24174870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Medication Adherence with the Use of Extended-Release Tacrolimus in Liver Transplant Recipients: A Pilot Randomized Controlled Trial.
    Verma M; Zaki R; Sadeh J; Knorr JP; Gallagher M; Parsikia A; Navarro V
    J Transplant; 2023; 2023():7915781. PubMed ID: 36642992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled Trial.
    McGillicuddy JW; Chandler JL; Sox LR; Taber DJ
    Ann Pharmacother; 2020 Dec; 54(12):1185-1193. PubMed ID: 32506922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized Trial of a Multicomponent Intervention to Promote Medication Adherence: The Teen Adherence in Kidney Transplant Effectiveness of Intervention Trial (TAKE-IT).
    Foster BJ; Pai ALH; Zelikovsky N; Amaral S; Bell L; Dharnidharka VR; Hebert D; Holly C; Knauper B; Matsell D; Phan V; Rogers R; Smith JM; Zhao H; Furth SL
    Am J Kidney Dis; 2018 Jul; 72(1):30-41. PubMed ID: 29602631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in medication adherence by sex and organ type among adolescent and young adult solid organ transplant recipients.
    Vaisbourd Y; Dahhou M; Zhang X; Sapir-Pichhadze R; Cardinal H; Johnston O; Blydt-Hansen TD; Tibbles LA; Hamiwka L; Urschel S; Birk P; Bissonnette J; Matsuda-Abedini M; BScPhm JH; Schiff J; Phan V; De Geest S; Allen U; Avitzur Y; Mital S; Foster BJ
    Pediatr Transplant; 2023 Mar; 27(2):e14446. PubMed ID: 36478059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated Reminders and Physician Notification to Promote Immunosuppression Adherence Among Kidney Transplant Recipients: A Randomized Trial.
    Reese PP; Bloom RD; Trofe-Clark J; Mussell A; Leidy D; Levsky S; Zhu J; Yang L; Wang W; Troxel A; Feldman HI; Volpp K
    Am J Kidney Dis; 2017 Mar; 69(3):400-409. PubMed ID: 27940063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial.
    Plischke M; Riegersperger M; Dunkler D; Heinze G; Kikić Ž; Winkelmayer WC; Sunder-Plassmann G
    PLoS One; 2015; 10(8):e0135674. PubMed ID: 26270340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: A randomized controlled trial.
    Han A; Min SI; Ahn S; Min SK; Hong HJ; Han N; Kim YS; Ahn C; Ha J
    PLoS One; 2019; 14(11):e0224595. PubMed ID: 31689320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing a personalized pharmaceutical plan in kidney or liver transplant patients: study protocol for a stepped-wedge cluster randomized trial (GRePH).
    Pourrat X; Berthy E; Dupuis A; Barbier L; Buchler M; Guillon LG; Monmousseau F; Ruspini E; Salamé E; Houdard SB; Giraudeau B
    Trials; 2021 Nov; 22(1):782. PubMed ID: 34749777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: Results of a randomized controlled pilot study.
    Taber DJ; Posadas-Salas A; Su Z; Rao V; Rohan V; Nadig S; McGillicuddy JW; Dubay D; Fleming JN
    Clin Transplant; 2020 Apr; 34(4):e13844. PubMed ID: 32092187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial.
    van Zanten R; de Weerd A; Betjes M; Boer-Verschragen M; Massey EK
    Transpl Int; 2021 Sep; 34(9):1703-1711. PubMed ID: 34448273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of adherence and tolerability of prolonged-release tacrolimus (Advagraf™) in kidney transplant patients in Germany: A multicenter, noninterventional study.
    Lehner LJ; Reinke P; Hörstrup JH; Rath T; Suwelack B; Krämer BK; Budde K; Banas B
    Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29052906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a home-based (multi) systemic intervention to promoting Medication AdheRence and Self-management among kidney transplant recipients with care-as-usual: the MARS randomized controlled trial protocol.
    Beck DK; Tielen M; Rechards M; Timman R; Boonstra C; Versteegh J; van de Wetering J; Zietse R; van Gelder T; Weimar W; van Saase J; van Busschbach J; Massey EK
    BMC Nephrol; 2020 Aug; 21(1):374. PubMed ID: 32859157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing medication adherence with home-monitoring - A feasibility study using capillary microsampling and mHealth in solid organ-transplanted adolescents.
    Kindem IA; Åsberg A; Midtvedt K; Bjerre A
    Pediatr Transplant; 2023 Nov; 27(7):e14590. PubMed ID: 37543722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients.
    Maurer MM; Ibach M; Plewe J; Winter A; Ritschl P; Globke B; Öllinger R; Lurje G; Schöning W; Pratschke J; Eurich D
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving medication adherence in adult kidney transplantation (IMAKT): A pilot randomised controlled trial.
    Low JK; Manias E; Crawford K; Walker R; Mulley WR; Toussaint ND; Dooley M; Kennedy E; Smith CL; Nalder M; Yip D; Williams A
    Sci Rep; 2019 May; 9(1):7734. PubMed ID: 31118485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.